Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Maintenance DNA methylation is essential for regulatory T cell development and stability of suppressive function
Kathryn A. Helmin, Luisa Morales-Nebreda, Manuel A. Torres Acosta, Kishore R. Anekalla, Shang-Yang Chen, Hiam Abdala-Valencia, Yuliya Politanska, Paul Cheresh, Mahzad Akbarpour, Elizabeth M. Steinert, Samuel E. Weinberg, Benjamin D. Singer
Kathryn A. Helmin, Luisa Morales-Nebreda, Manuel A. Torres Acosta, Kishore R. Anekalla, Shang-Yang Chen, Hiam Abdala-Valencia, Yuliya Politanska, Paul Cheresh, Mahzad Akbarpour, Elizabeth M. Steinert, Samuel E. Weinberg, Benjamin D. Singer
View: Text | PDF
Research Article Autoimmunity Immunology

Maintenance DNA methylation is essential for regulatory T cell development and stability of suppressive function

  • Text
  • PDF
Abstract

Tregs require Foxp3 expression and induction of a specific DNA hypomethylation signature during development, after which Tregs persist as a self-renewing population that regulates immune system activation. Whether maintenance DNA methylation is required for Treg lineage development and stability and how methylation patterns are maintained during lineage self-renewal remain unclear. Here, we demonstrate that the epigenetic regulator ubiquitin-like with plant homeodomain and RING finger domains 1 (Uhrf1) is essential for maintenance of methyl-DNA marks that stabilize Treg cellular identity by repressing effector T cell transcriptional programs. Constitutive and induced deficiency of Uhrf1 within Foxp3+ cells resulted in global yet nonuniform loss of DNA methylation, derepression of inflammatory transcriptional programs, destabilization of the Treg lineage, and spontaneous inflammation. These findings support a paradigm in which maintenance DNA methylation is required in distinct regions of the Treg genome for both lineage establishment and stability of identity and suppressive function.

Authors

Kathryn A. Helmin, Luisa Morales-Nebreda, Manuel A. Torres Acosta, Kishore R. Anekalla, Shang-Yang Chen, Hiam Abdala-Valencia, Yuliya Politanska, Paul Cheresh, Mahzad Akbarpour, Elizabeth M. Steinert, Samuel E. Weinberg, Benjamin D. Singer

×

Figure 5

Induced loss of Uhrf1 in Tregs results in generation of ex-Foxp3 cells.

Options: View larger image (or click on image) Download as PowerPoint
Induced loss of Uhrf1 in Tregs results in generation of ex-Foxp3 cells.
...
(A) Representative flow cytometry contour plots gated on splenic CD3ε+CD4+tdTomato+ cells showing the percentage of ex-Foxp3 (Foxp3-GFP–) and Treg (Foxp3-GFP+) cells after 4 weeks of tamoxifen started at either 4 or 8 weeks of age. (B) Summary data of the percentage of ex-Foxp3 and Tregs within the tdTomato+ population for the experiments shown in A. (C) Ratio of ex-Foxp3 to Tregs after 4 weeks of tamoxifen started at either 4 or 8 weeks of age. For mice started on tamoxifen at 4 weeks of age, n = 5 (iUhrf1+/+) and n = 18 (iUhrf1fl/fl); for mice started on tamoxifen at 8 weeks of age, n = 4 (iUhrf1+/+) and n = 8 (iUhrf1fl/fl). (D) Total cell numbers of ex-Foxp3 and Tregs. For mice started on tamoxifen at 4 weeks of age, n = 5 (iUhrf1+/+) and n = 7 (iUhrf1fl/fl); for mice started on tamoxifen at 8 weeks of age, n = 4 (iUhrf1+/+) and n = 7 (iUhrf1fl/fl). *q < 0.05; **p or q < 0.01; †p or q < 0.001; NS, not significant by Mann-Whitney U test (C) or the 2-stage linear step-up procedure of Benjamini, Krieger, and Yekutieli with Q = 5% (B and D); exact p and q values are in Supplemental Data.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts